By: Julie Masse

Chemistry is still cool
April 7, 2015

Looking for new customers in France, Belgium, United Kingdom, and other European countries, I realized that the number of pharmaceutical companies…

Read More
GalChimia is part of the consortium selected by the H2020 EU for grant funding of €7.9 million
March 30, 2015

GalChimia is part of the consortium selected by the H2020 EU for grant funding of €7.9 million. Santiago, Spain, 30 March…

Read More
Galchimia assisted to BioEurope Spring 2015 in Paris
March 19, 2015

We were happy to join and have a stand to this important meeting. Our stand was managed by Bioga, the Galician…

Read More
Who had come in first ?
February 19, 2015

Being French, living in Spain and working in English I read different news items from different countries in several languages. Recently,…

Read More
Case Study: Custom Synthesis
February 9, 2015

In 2014 we were approached to prepare an intermediate in bulk. Our customer had specific issues finding suppliers for this product….

Read More
Case Study: Medicinal Chemistry
February 2, 2015

In 2012 we were asked to develop a Me-Better for a compound currently in Clinical Phase III. The product was developed…

Read More
Cancer, Bad Luck and Press Releases…
January 26, 2015

Everything started with a headline: “Most cancers are caused by bad luck – not bad judgement, says study” (Independent), and another:…

Read More
Are cars becoming more innovative than drugs?
December 12, 2014

For the first time in 10 years there is no pharmaceutical company among the three biggest R&D spenders! According to the…

Read More